Sulfuric Acid

Sulfuric Acid

SCHEMBL6380732

O=S(=O)([O-])O.O=S(=O)([O-])O.[Zn+2]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.80
MEN1 O00255 1/20 0.80
ALDH1A1 P00352 1/20 0.80
KMT2A Q03164 1/20 0.80
CA5A P35218 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
CA2 P00918 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CA1 P00915 1/20 0.42
NT5E P21589 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
TP53 P04637 1/20 0.35
BLM P54132 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28489318 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL28185521 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL28904704 0.95 TSHR (0.90) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL5915088 0.95
Sulfuric Acid SCHEMBL1674710 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL28413973 0.95
Sulfuric Acid SCHEMBL1052296 0.95
Sulfuric Acid SCHEMBL23202724 0.91 TSHR (0.67) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL11142512 0.91 TSHR (0.67) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL27971224 0.91 TSHR (0.67) TSHRMEN1ALDH1A1KMT2ACA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118388695-A Preparation method of vinyl acetate-ethylene copolymer emulsion with high solid content and low viscosity 广西皖维生物质科技有限公司 2024-07-26 CN claimed
CN-117417393-A Method for separating and recovering fructose from 5-hydroxymethylfurfural production wastewater 中科国生(杭州)科技有限公司 2024-01-19 CN claimed
CN-116693476-A Preparation method of 2, 5-dimethyl furandicarboxylate 中科国生(泰兴)新材料科技有限公司 2023-09-05 CN claimed
US-11512026-B2 Use of zinc salts in combination with alkyl amines in cement-based dry mortar mixtures CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2022-11-29 US claimed
EP-3609605-B1 METHOD OF MAKING SULFIDE SCAVENGING NANOPARTICLES ECOLAB USA INC (US) 2021-12-01 EP claimed
EP-3710416-B1 USE OF ZINC SALTS IN COMBINATION WITH ALKYLAMINES IN CEMENTITIOUS DRY MORTAR MIXTURES CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2021-10-20 EP claimed
EP-3710416-A1 USE OF ZINC SALTS IN COMBINATION WITH ALKYL AMINES IN CEMENT-BASED DRY MORTAR MIXTURES Construction Research & Technology GmbH (DE) 2020-09-23 EP claimed
US-20200277236-A1 USE OF ZINC SALTS IN COMBINATION WITH ALKYL AMINES IN CEMENT-BASED DRY MORTAR MIXTURES SIKA TECHNOLOGY AG (CH) 2020-09-03 US claimed
EP-3609605-A1 MICROPARTICLES FOR CAPTURING MERCAPTANS Ecolab USA, Inc. (US) 2020-02-19 EP claimed
US-20180291284-A1 MICROPARTICLES FOR CAPTURING MERCAPTANS ECOLAB USA INC. (US) 2018-10-11 US claimed
US-20120264933-A1 EFFICIENT PROCESS TO INDUCE ENANTIOSELECTIVITY IN PROCARBONYL COMPOUNDS LAURUS LABS PRIVATE LIMITED (IN) 2012-10-18 US claimed
CN-101721375-B Insulin sustained-release microsphere composition and preparation method thereof UNIV SHANGHAI JIAOTONG 2012-05-30 CN claimed
CN-101440080-B Mechanochemical preparation of flavonoid UNIV ZHEJIANG TECHNOLOGY 2011-05-25 CN claimed
CN-101440065-B Mechanochemical preparation of 1,3,5-triaryl-2-pyrazoline compounds UNIV ZHEJIANG TECHNOLOGY 2011-05-25 CN claimed
CN-101721375-A Insulin slow release micron sphere composition and preparation method thereof UNIV SHANGHAI JIAOTONG 2010-06-09 CN claimed
CN-100571867-C The Catalysts and its preparation method of cracking isobutene by methyl-tert-butyl ether ZHEJIANG UNIVERSITY ZHEJIANG J (CN) 2009-12-23 CN claimed
CN-101440080-A Mechanochemical preparation of flavonoid UNIV ZHEJIANG TECHNOLOGY (CN) 2009-05-27 CN claimed
CN-101440065-A Mechanochemical preparation of 1,3,5-triaryl-2-pyrazoline compounds UNIV ZHEJIANG TECHNOLOGY (CN) 2009-05-27 CN claimed
CN-101020142-A Catalyst for cracking methyl tert-butyl ether to prepare isobutylene and its prepn UNIV ZHEJIANG (CN) 2007-08-22 CN claimed
US-6610756-B1 Fireproof SANYO CHECMICAL INDUSTRIES, LTD. (JP) 2003-08-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264933-A1 EFFICIENT PROCESS TO INDUCE ENANTIOSELECTIVITY IN PROCARBONYL COMPOUNDS OTC, MCCC2, SLC6A5 TSHR 4456/4885MEN1 1139/4885ALDH1A1 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.